Objective Analysis of Caesarean Scar Pregnancy

The Predictive Value of an Ultrasound Quantitative Scoring System for Treatment Method Selection in Patients With Caesarean Scar Pregnancy: A Single-Centre Retrospective Study

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06276790

Enrollment

117

Registered

2024-02-26

Start date

2019-01-18

Completion date

2022-12-25

Last updated

2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Caesarean Scar Pregnancy, Ultrasound Scoring System

Brief summary

This study uses a systematic scoring method combined with clinical and ultrasound data to comprehensively evaluate patient conditions and explore the guiding value of the ultrasound quantitative scoring system for selecting the surgical approach for caesarean scar pregnancy.

Interventions

PROCEDUREultrasound-guided/hysteroscopic curettage

ultrasound-guided/hysteroscopic curettage

PROCEDUREProcedure/Surgery: laparoscopic removal of the pregnancy lesion

laparoscopic removal of the pregnancy lesion

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

20 Years to No maximum

Inclusion criteria

* history of at least one previous caesarean section * symptoms suggestive of caesarean scar pregnancy, such as unexplained abnormal vaginal bleeding, abdominal pain, cervical pain or abnormal uterine activity during pregnancy * amenorrhea ≤84 days * ultrasound examination suggesting a single gestational sac with intact morphology * stable maternal vital signs

Exclusion criteria

* mass-type caesarean scar pregnancy * previous medication or surgical treatment before ultrasound examination * haemodynamically unstable patients * patients with surgical contraindications * incomplete or lost follow-up clinical data * patients with severe medical conditions such as hypertension, diabetes, hyperthyroidism and haemophilia

Design outcomes

Primary

Measure	Time frame	Description
intraoperative blood loss	during surgery	The patient's blood loss during surgery. Check the blood volume in ml of the aspirator reservoir.
length of hospital stay	Within 1 week	Number of days the patient was hospitalized. Discharge assessment: vital signs stable, no abdominal pain, no active bleeding.
serum β-HCG levels	Within 2 weeks after the operation	The time taken for serum β-HCG levels to return to normal

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026